Literature DB >> 2531090

DNA fragmentation and cell death mediated by T cell antigen receptor/CD3 complex on a leukemia T cell line.

S Takahashi1, H T Maecker, R Levy.   

Abstract

An anti-T cell receptor (TcR) monoclonal antibody (mAb), LC4, directed against a human leukemic T cell line, SUP-T13, caused DNA fragmentation ("apoptosis") and cell death upon binding to this cell line. Cross-linking of receptor molecules was necessary for this effect since F(ab')2, but not Fab', fragments of LC4 could induce cell death. Five anti-CD3 mAb tested also caused apoptosis, but only when they were presented on a solid phase. Interestingly, soluble anti-CD3 mAb induced calcium flux and had an additive effect on the calcium flux and interleukin 2 receptor expression induced by LC4, but these anti-CD3 mAb reversed the growth inhibition and apoptosis caused by LC4. The calcium ionophore A23187, but not the protein kinase C activator phorbol 12-myristate 13-acetate (PMA), also induced apoptosis, suggesting that protein kinase C activation alone does not cause apoptosis, although PMA is growth inhibitory. These results suggest that two distinct biological phenomena can accompany stimulation of the TcR/CD3 complex. In both cases, calcium flux and interleukin 2 receptor expression is induced, but only in one case is apoptosis and cell death seen. The signal initiating apoptosis can be selectively prevented by binding CD3 portion of the receptor in this cell line. This difference in signals mediated by the TcR/CD3 complex may be important in explaining the process of thymic selection, as well as in choosing anti-TcR mAb for therapeutic use.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2531090     DOI: 10.1002/eji.1830191023

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  11 in total

1.  Reactive oxygen species involved in trichosanthin-induced apoptosis of human choriocarcinoma cells.

Authors:  C Zhang; Y Gong; H Ma; C An; D Chen; Z L Chen
Journal:  Biochem J       Date:  2001-05-01       Impact factor: 3.857

2.  Increased protection from vaccinia virus infection in mice genetically prone to lymphoproliferative disorders.

Authors:  Mina O Seedhom; Keisha S Mathurin; Sung-Kwon Kim; Raymond M Welsh
Journal:  J Virol       Date:  2012-03-21       Impact factor: 5.103

3.  T cells deficient in inositol 1,4,5-trisphosphate receptor are resistant to apoptosis.

Authors:  T Jayaraman; A R Marks
Journal:  Mol Cell Biol       Date:  1997-06       Impact factor: 4.272

4.  Transient elevations of cytosolic free calcium retard subsequent apoptosis in neutrophils in vitro.

Authors:  M K Whyte; S J Hardwick; L C Meagher; J S Savill; C Haslett
Journal:  J Clin Invest       Date:  1993-07       Impact factor: 14.808

5.  Functional and molecular aspects of transient T cell unresponsiveness: role of selective interleukin-2 deficiency.

Authors:  M D Köller; H P Kiener; M Aringer; W B Graninger; S Meuer; Y Samstag; J S Smolen
Journal:  Clin Exp Immunol       Date:  2003-05       Impact factor: 4.330

6.  Detection of T cells responsive to a vascular growth factor in rheumatoid arthritis.

Authors:  V M Byrd; X M Zhao; G G Miller; J W Thomas
Journal:  Immunol Res       Date:  1994       Impact factor: 2.829

7.  Distribution of apoptosis-mediating Fas antigen in human skin and effects of anti-Fas monoclonal antibody on human epidermal keratinocyte and squamous cell carcinoma cell lines.

Authors:  M Oishi; K Maeda; S Sugiyama
Journal:  Arch Dermatol Res       Date:  1994       Impact factor: 3.017

8.  Activation of phospholipase D: a signaling system set in motion by perturbation of the T lymphocyte antigen receptor/CD3 complex.

Authors:  S J Stewart; G R Cunningham; J A Strupp; F S House; L L Kelley; G S Henderson; J H Exton; S B Bocckino
Journal:  Cell Regul       Date:  1991-10

9.  Induction of specific nonresponsiveness in unprimed human T cells by anti-CD3 antibody and alloantigen.

Authors:  C Anasetti; P Tan; J A Hansen; P J Martin
Journal:  J Exp Med       Date:  1990-12-01       Impact factor: 14.307

10.  An Epstein-Barr virus-associated superantigen.

Authors:  N Sutkowski; T Palkama; C Ciurli; R P Sekaly; D A Thorley-Lawson; B T Huber
Journal:  J Exp Med       Date:  1996-09-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.